Sekarang ati ati kalo mengkonsumsi obat emplu (baca : flu),
Ini ada berita baru bahwa obat flu yg mengandung Phenylpropanolamine
(spt Decolgen, Stop Cold,dsb) harus ditarik dari peredaran karena bisa
menyebabkan stroke. 
Di singapore akan ditarik dan di Amerika sudah ditarik. Jadi hati-hati kalau 
mengkonsumsi obat flu yang mengandung bahan tsb.

Daftarnya ada dibawah
semoga bermanfaat...

NATIONAL PHARMACEUTICAL ADMINISTRATION
Ministry of Health
2 Jalan Bukit Merah Singapore 169547
http://www.gov.sg/moh/npa/index.html

HEALTHCARE PROFESSIONAL CIRCULAR NO.1/2000

14 November 2000

Dear Health Care Professional

WITHDRAWAL OF PHENYLPROPANOLAMINE (PPA) PRODUCTS

The Ministry of Health has asked all pharmaceutical companies marketing
products containing phenylpropanolamine (PPA) to voluntarily withdraw and discontinue 
the distribution of these products in Singapore. 
This is a precautionary measure in line with the recent call by the US Food and Drug 
Administration (FDA) for voluntary discontinuation of marketing of such products in 
the USA.

Phenylpropanolamine (PPA) is a sympathomimetic agent, commonly found in
cough, cold and allergy medications. It is classified as a Pharmacy Medicine in 
Singapore.
In the United States, PPA is popular as an over-the-counter cough and cold medicine as 
well as a slimming agent.

Case reports have linked exposure to PPA to the occurrence of haemorrhagic stroke. 
Many of the affected patients have been young women using PPA as an
appetite suppressant, often after a first dose. 
To further examine the association between PPA and haemorrhagic stroke, the Yale 
University Medical School designed a case-control study involving men and women ages 
18 to 49 years who were hospitalised with a subarachnoid haemorrhage (SAH) or 
intracerebral haemorrhage (ICH). Eligible case subjects had no prior history of stroke 
and were able to participate in an interview within 30 days of their event. 
Case subjects were recruited from hospitals in 4 geographic regions of the United 
States.

The final study cohort comprised 702 case subjects who were matched by
demographic characteristics with 1,367 controls who had not had strokes.
Age matching was successful for 1,367 controls (99%) and ethnicity matching was 
achieved for 1,321 controls (96%). For the association between haemorrhagic stroke and 
any use of PPA within 3 days, the adjusted odds ratio was 1.49 (lower limit of the 
one-sided 95% confidence interval (LCL) = 0.93, p =0.084). 
For the association between haemorrhagic stroke and PPA use in
cough/cold remedies within the 3-day exposure window, the adjusted odds
ratio was 1.23 (LCL = 0.75, p = 0.245).
For the association between haemorrhagic stroke and PPA use in appetite suppressants 
within the 3-day exposure window, the adjusted odds ratio was 15.92 (LCL = 2.04, p = 
0.013).
For the association between PPA in appetite suppressants and risk for
haemorrhagic stroke among women, the adjusted odds ratio was 16.58 
(LCL = 2.22, p = 0.011). 
For first dose PPA uses among women, the adjusted odds ratio was 3.13 (LCL = 1.05, p = 
0.042).
All first dose PPA use involved cough/cold remedies.

In conclusion, the results of the HSP suggest that PPA increases the risk for 
haemorrhagic stroke.

The HSP is a case control study and there are limitations for definitive conclusions. 
However, the overall assessment was that the study was well-designed and executed. All 
reasonable steps were taken to minimise bias and confounding. 
The Ministry has also considered the HSP report in the context of the spontaneous 
reports of haemorrhagic stroke received by the US FDA during the period 1991 - 2000.
Although the risk of haemorrhagic stroke is very low, the Ministry has significant 
concerns because of the seriousness of this adverse event (the irreversible outcome) 
and the inability to predict who is at risk. The Ministry does not consider the 
conditions for which PPA is used as justifying the risk of this serious event as 
alternative cough and cold medications which do not contain PPA are available for use.

All doctors and pharmacists are advised not to prescribe or sell
PPA-containing medications to patients. Please also reassure your patients that there 
is no risk of adverse effects once PPA-containing products are no longer being taken.
Patients who have previously taken PPA-containing products also do not have to be 
worried about their health as there are no long term adverse effects from 
PPA-containing products.

The list of PPA-containing cough and cold remedies available in Singapore is enclosed 
at Annex.

If you need further clarification, please contact Ms Chan Cheng Leng, Head ation & 
Research) Unit, National Pharmaceutical Administration, at
telephone 3255610

Yours sincerely

DR JOHN LIM
DIRECTOR
NATIONAL PHARMACEUTICAL ADMINISTRATION
MINISTRY OF HEALTH

cc:  
President, SMA
President, PSS
Master, Academy of Me
Annex

Combination Products Containing PPA in Singapore

S/No. Name of Product Active Ingredients Strength

1 ACCOL TABLET PARACETAMOL 500 mg
  CHLORPHENIRAMINE MALEATE 4 mg
  PHENYLPROPANOLAMINE HCl 25 mg

2 ALLERIN EXPECTORANT DIPHENHYDRAMINE HCl 12.5 mg/5 ml
  GUAIPHENESIN 50 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml
  SODIUM CITRATE 180 mg/5 ml

3 ANTIKOF SYRUP TRIMEPRAZINE TARTRATE 2.5 mg/5 ml
  PHENYLPROPANOLAMINE HCl 10 mg/5 ml
  GUAIPHENESIN 25 mg/5 ml
  IPECACUANHA TINCTURE 0.015 ml/5 ml

4 BEACOGEN TABLET PARACETAMOL 500 mg
  PHENYLPROPANOLAMINE HCl 12.5 mg
  DEXCHLORPHENIRAMINE MALEATE 1 mg

5 BEAFLU TABLETS PARACETAMOL 500 mg
  CHLORPHENIRAMINE MALEATE 2 mg
  PHENYLPROPANOLAMINE HCl 25 mg

6 BROMANATE ELIXIR BROMPHENIRAMINE MALEATE 2 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml

7 COLD SPECIAL SYRUP BROMPHENIRAMINE MALEATE 2 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml

8 COLDACHE TABLET PARACETAMOL 500 mg
  PHENYLPROPANOLAMINE HCl 15 mg
  CHLORPHENIRAMINE MALEATE 2 mg

9 CONTAC 400 CAPSULE PHENYLPROPANOLAMINE HCl 50 mg
  CHLORPHENIRAMINE MALEATE 4 mg

10 CORITAB TABLET PARACETAMOL 500 mg
  PHENYLPROPANOLAMINE HCl 25 mg
  CHLORPHENIRAMINE MALEATE 2 mg

11 CORITUSSAL SYRUP DEXTROMETHORPHAN 120 mg/100 g
  PHENYLPROPANOLAMINE 300 mg/100 g
  CARBINOXAMINE 24 mg/100 g

12 COUGH SPECIAL SYRUP TRIPROLIDINE HCl 1.25 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml
  CODEINE PHOSPHATE 10 mg/5 ml


S/No. Name of Product Active Ingredients Strength

13 CTP COUGH FORMULA TRIPROLIDINE HCl 1.25 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml
  CODEINE PHOSPHATE 10 mg/5 ml

14 DE- COLD ELIXIR BROMPHENIRAMINE MALEATE 4 mg/10ml
  PHENYLPROPANOLAMINE HCL 25 mg/10ml

15 DECOLDIN TABLET PARACETAMOL 480 mg
  PHENYLPROPANOLAMINE HCl 12.5 mg
  CHLORPHENIRAMINE MALEATE 2 mg

16 DECOLGEN FORTE TABLET ACETAMINOPHEN 500 mg
  PHENYLPROPANOLAMINE HCl 25 mg
  CHLORPHENIRAMINE MALEATE 2 mg

17 DECOLGEN LIQUID ACETAMINOPHEN 300 mg/15 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/15 ml
  CHLORPHENIRAMINE MALEATE 1 mg/15 ml

18 DECOLGEN TABLET ACETAMINOPHEN 300 mg
  PHENYLPROPANOLAMINE HCl 12.5 mg
  CHLORPHENIRAMINE MALEATE 1 mg
  ASCORBIC ACID 25 mg

19 DELIX PAEDIATRIC LINCTUS PHENYLPROPANOLAMINE HCl 10 mg/5 ml
  PROMETHAZINE HCl 1.5 mg/5 ml
  PHOLCODINE CITRATE 1.5 mg/5 ml

20 DEXEDYL LINCTUS DEXTROMETHORPHAN HBr 15 mg/10 ml
  PHENYLPROPANOLAMINE HCl 15 mg/10 ml
  CHLORPHENIRAMINE MALEATE 2 mg/10 ml

21 DHAFLU TABLET PARACETAMOL 500 mg
  CHLORPHENIRAMINE MALEATE 3 mg
  PHENYLPROPANOLAMINE HCl 20 mg
  CAFFEINE ANHYDROUS 30 mg

22 DIMETAPP ELIXIR PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml
  BROMPHENIRAMINE MALEATE 2 mg/5 ml

23 DIMETAPP EXTENTABS BROMPHENIRAMINE MALEATE 12 mg
  PHENYLPROPANOLAMINE HCl 75 mg

24 DYNACOLIN TABLET PARACETAMOL 500 mg
  PHENYLPROPANOLAMINE HCl 25 mg
  CHLORPHENIRAMINE MALEATE 4 mg

25 EAZKOFF COUGH AND COLD LINCTUS PHENYLPROPANOLAMINE HCl 10 mg/5 ml
  TRIMEPRAZINE TARTRATE 2.5 mg/5 ml
  GUAIPHENESIN 25 mg/5 ml

S/No. Name of Product Active Ingredients Strength

26 FEBRICOL ELIXIR PARACETAMOL 162.5 mg/5 ml
  CHLORPHENIRAMINE MALEATE 1 mg/5 ml
  PHENYLPROPANOLAMINE HCl 6.25 mg/5 ml

27 FEBRICOL TABLET PARACETAMOL 500 mg
  PHENYLPROPANOLAMINE HCl 15 mg
  CHLORPHENIRAMINE MALEATE 2 mg

28 FLU FORTE SYRUP CHLORPHENIRAMINE MALEATE 4 mg/5 ml
  PHENYLPROPANOLAMINE HCl 25 mg/5 ml

29 FLUTAMIN COLD FORMULA CHLORPHENIRAMINE MALEATE 4 mg/5 ml
  PHENYLPROPANOLAMINE HCl 25 mg/5 ml

30 GUARDIAN COUGH & COLD SYRUP GUAIFENESIN 50 mg/5 ml
  PHENYLPROPANOLAMINE HCl 6.25 mg/5 ml

31 MEHISDIN SYRUP CHLORPHENIRAMINE MALEATE 2 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml
  SODIUM CITRATE 40 mg/5 ml

32 MENDICOF SYRUP DEXCHLORPHENIRAMINE MALEATE 2 mg/5 ml
  DEXTROMETHORPHAN HBr 15 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml

33 MILIDON-CO TABLET CHLORPHENIRAMINE MALEATE 2 mg
  PARACETAMOL 500 mg
  PHENYLPROPANOLAMINE HCl 12.5 mg

34 NASATAB TABLET PARACETAMOL 500 mg
  CHLORPHENIRAMINE MALEATE 4 mg
  PHENYLPROPANOLAMINE HCl 25 mg

35 NOBIS TABLET BROMPHENIRAMINE MALEATE 4 mg
  PHENYLPROPANOLAMINE HCl 25 mg

36 P3 COUGH SYRUP PHOLCODINE 3 mg/5 ml
  PROMETHAZINE HCl 3 mg/5 ml
  PHENYLPROPANOLAMINE HCl 6 mg/5 ml

37 PAEDICOF SYRUP DEXCHLORPHENIRAMINE MALEATE 0.5 mg/5 ml
  DEXTROMETHORPHAN HBr 5 mg/5 ml
  PHENYLPROPANOLAMINE HCl 6.25 mg/5 ml

38 PANAFLU PLUS TABLET PARACETAMOL 500 mg
  CHLORPHENIRAMINE MALEATE 2 mg
  PHENYLPROPANOLAMINE HCl 25 mg
  CAFFEINE ANHYDROUS 15 mg

39 PANAFLU TABLET PARACETAMOL 300 mg
  CHLORPHENIRAMINE MALEATE 2 mg
  PHENYLPROPANOLAMINE HCl 25 mg

S/No. Name of Product Active Ingredients Strength

40 PARAMINE TABLET PARACETAMOL 500 mg
  PHENYLPROPANOLAMINE HCl 15 mg
  CHLORPHENIRAMINE MALEATE 2 mg

41 PARCLORPHEN TABLET PARACETAMOL 300 mg
  PHENYLPROPANOLAMINE HCl 12.5 mg
  CHLORPHENIRAMINE MALEATE 2 mg

42 PEDILIX COUGH LINCTUS PROMETHAZINE HCl 1.5 mg/5 ml
  PHOLCODINE 1.5 mg/5 ml
  PHENYLPROPANOLAMINE HCl 10 mg/5 ml

43 PROFLU TABLET PARACETAMOL 300 mg
  CHLORPHENIRAMINE MALEATE 1 mg
  PHENYLPROPANOLAMINE Hcl 12.5 mg
  ASCORBIC ACID 25 mg

44 RHINOPRONT SYRUP PHENYLPROPANOLAMINE 300 mg/90 ml
  CARBINOXAMINE 24 mg/90 ml

45 ROBITUSSIN-CF SYRUP GUAIPHENESIN 100 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/ 5ml
  DEXTROMETHORPHAN HBr 10 mg/5 ml

46 SINUZIN-D TABLETS PARACETAMOL 325 mg
  PHENYLPROPANOLAMINE HCl 12.5 mg
  CHLORPHENIRAMINE MALEATE 2 mg

47 SYNCOLDTAB-M TABLET PHENYLPROPANOLAMINE HCl 25 mg
  CHLORPHENIRAMINE MALEATE 2 mg

48 TEMPRO SUSPENSION PARACETAMOL 250 mg/5 ml
  PHENYLPROPANOLAMINE HCl 10 mg/5 ml
  CHLORPHENIRAMINE MALEATE 2 mg/5 ml
49 TRIPRO SYRUP TRIPROLIDINE HCl 1.25 mg/5 ml
  PHENYLPROPANOLAMINE HCl 12.5 mg/5 ml

50 UNIRHINOL FORTE TABLET PARACETAMOL 500 mg
  CHLORPHENIRAMINE MALEATE 4 mg
  PHENYLPROPANOLAMINE HCl 25 mg

51 UNIRHINOL TABLET PARACETAMOL 500 mg
  CHLORPHENIRAMINE MALEATE 2 mg
  PHENYLPROPANOLAMINE HCl 25 mg

52 UPHAMIN CAPSULE PARACETAMOL 250 mg
  CHLORPHENIRAMINE MALEATE 2 mg
  PHENYLPROPANOLAMINE HCl 12.5 mg

53 WALEKOF SYRUP TRIMEPRAZINE TARTRATE 2.5 mg/5 ml
  PHENYLPROPANOLAMINE HCl 10 mg/5 ml
  GUAIPHENESIN 25 mg/5 ml

Thanks
Doddy Mulyadi
Supply Chain Dept  
Philips Ralin Electronics
Jl. Berbek Industri I kav. 5 - 19
Sidoarjo 61256

Phone 62-031-8491674 ext. 234
Fax       62-031-8437561
E-mail : [EMAIL PROTECTED]

>>>> 2.5 Mbps InternetShop >> InternetZone << Margonda Raya 340 <<<<
>> Cake, parcel lebaran & bunga2 Natal? Klik, http://www.indokado.com
>> Info balita, http://www.balita-anda.indoglobal.com
Etika berinternet, email ke: [EMAIL PROTECTED]
Stop berlangganan, e-mail ke: [EMAIL PROTECTED]
















Kirim email ke